Taking the fight against AIDS to a new level

After major breakthroughs that have twice changed the worldwide norm of AIDS therapy within the past 15 years, British Columbia’s pioneering treatment/research centre is taking the fight against the disease to a new level.

Feeding on its own convincing evidence that the more aggressively you treat HIV, the more you reduce the chance of the virus being spread to others, the B.C. Centre for Excellence in HIV/AIDS is the inspiration behind a bold, four-year project to seek out the most difficult and vulnerable AIDS population of all.

Those are the thousands of individuals in the province who don’t know they have the virus, or, who do know, but are not receiving treatment.

“We are going to go where the people are,” says Susan Burgess, a physician working in the drug-ravaged Downtown Eastside who has about 160 AIDS patients. “If we can find them, we can give them effective care.”

More >>

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below